title: [Mitral valve interventions: Where do we stand?].
abstract: Mitral valve regurgitation (MR) with resulting heart failure is one of the most prevalent types of valvular heart disease. Currently, various approaches to catheter-based therapy of MR are already available for patients deemed to be at high-risk for surgery. Most experience has been gained with the MitraClip® system. Technological developments in the field of catheter-based treatment of MR is advancing at a rapid pace, with treatment modalities suited for patients with both primary and secondary MR. Annuloplasty is the surgical gold standard, particularly for patients with secondary MR. For catheter-based therapy of secondary MR a distinction is made between indirect and direct annuloplasty, with the latter most closely corresponding to surgical ring implantation. Catheter-based mitral valve replacement is technically feasible at present; however, experience is still limited and only few reports have been published. Technological development is markedly slower than in the field of transcatheter aortic valve replacement, predominantly owing to the far more complex structure of the mitral valve. Positive experience has already been gained with catheter-based implantation of prostheses designed for the aortic valve into degenerated mitral valve bioprostheses and failed surgical mitral annuloplasty rings (valve-in-valve and valve-in-ring implantation). Further approaches to catheter-based treatment of MR in high-risk surgical patients are expected in the future.
authors.affiliation: Klinik für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland,, c.frerker@asklepios.com.
authors.forename: C
authors.initials: C
authors.lastname: Frerker
authors.forename: T
authors.initials: T
authors.lastname: Schmidt
authors.forename: F
authors.initials: F
authors.lastname: Kreidel
authors.forename: M
authors.initials: M
authors.lastname: Schlüter
authors.forename: K-H
authors.initials: KH
authors.lastname: Kuck
mesh_terms: D006328:Cardiac Catheterization / Q000295:instrumentation* / Q000379:methods*; D019317:Evidence-Based Medicine; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D058386:Mitral Valve Annuloplasty / Q000295:instrumentation / Q000379:methods*; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000601:surgery*; D018579:Patient Selection; D011474:Prosthesis Design; D012307:Risk Factors; D016896:Treatment Outcome